aplastic anemia | Page 43 | Aplastic Anemia & MDS International Foundation

aplastic anemia

Comparison of Rabbit Antithymocyte Globulin (R-ATG) and Jurkat Cell-Reactive Anti-T Lymphocyte Globulin (ATG-F) as a First-line Treatment for Children with Aplastic Anemia

Author(s): 
Xie X, Shi W, Zhou X, Shao Y, Qiao X
Primary Author: 
Xie X
Journal Title: 
Exp Hematol
Original Publication Date: 
Feb 2014

OBJECTIVE:

To investigate the effects of rabbit anti-human thymocyte globulin (R-ATG) and Jurkat cell-reactive anti-T lymphocyte

Bone Marrow Diseases: 

Reduced intensity conditioning, combined transplantation of haploidentical hematopoietic stem cells and mesenchymal stem cells in patients with severe aplastic anemia

Author(s): 
Li XH, Gao CJ, Da WM, Cao YB, Wang ZH, Xu LX, Wu YM, Liu B, Liu ZY, Yan B, Li SW, Yang XL, Wu XX, Han ZC
Primary Author: 
Li XH
Journal Title: 
PLoS One
Original Publication Date: 
Mar 2014

We examined if transplantation of combined haploidentical hematopoietic

Bone Marrow Diseases: 

Pilot trial of risk-adapted cyclophosphamide intensity based conditioning and HLA matched sibling and unrelated cord blood stem cell transplantation in newly diagnosed pediatric and adolescent recipients with acquired severe aplastic anemia

Author(s): 
McGuinn C, Geyer MB, Jin Z, Garvin JH, Satwani P, Bradley MB, Bhatia M, George D, Duffy D, Morris E, van de Ven C, Schwartz J, Baxter-Lowe LA, Cairo MS
Primary Author: 
McGuinn C
Journal Title: 
Pediatr Blood Cancer
Original Publication Date: 
Feb 2014

BACKGROUND:

Bone Marrow Diseases: 

A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia

Author(s): 
Ashizawa M, Akahoshi Y, Nakano H, Ugai T, Wada H, Yamasaki R, Ishihara Y, Kawamura K, Sakamoto K, Sato M, Terasako K, Kimura SI, Kikuchi M, Nakasone H, Kako S, Kanda J, Yamazaki R, Tanihara A, Nishida J, Kanda Y
Primary Author: 
Ashizawa M
Journal Title: 
Int J Hematol
Original Publication Date: 
Feb 2014

Conditioning regimens consisting of reduced-dose

Bone Marrow Diseases: 

Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia

Author(s): 
Scheinberg P, Townsley D, Dumitriu B, Scheinberg P, Weinstein B, Rios O, Wu CO, Young NS
Primary Author: 
Scheinberg P
Journal Title: 
Am J Hematol
Original Publication Date: 
Jan 2014

The effectiveness of salvage therapy for

Bone Marrow Diseases: 

Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myeloid leukemia following aplastic anemia

Author(s): 
Yoshimi A, Strahm B, Baumann I, Furlan I, Schwarz S, Teigler-Schlegel A, Walther JU, Schlegelberger B, Göhring G, Nöllke P, Führer M, Niemeyer CM
Primary Author: 
Yoshimi A
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
Dec 2013

Secondary myelodysplastic syndrome and

Bone Marrow Diseases: